← FDA Drug Approvals (Drugs@FDA)

ADVIL DUAL ACTION WITH ACETAMINOPHEN

NDA · New Drug Application · Sponsor: HALEON US HOLDINGS · Approved 2020-02-28

Drug application

FDA Application #
NDA211733
Application type
New Drug Application
Brand name
ADVIL DUAL ACTION WITH ACETAMINOPHEN
Generic name
IBUPROFEN, ACETAMINOPHEN
Active ingredients
ACETAMINOPHEN; IBUPROFEN
Dosage form
TABLET
Route
ORAL
Marketing status
Over-the-counter
Sponsor
HALEON US HOLDINGS
Manufacturer
Haleon US Holdings LLC
First approval
2020-02-28

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown